潤達醫療(603108.SH)股東朱文怡質押2342萬股及解質1246.3萬股
格隆匯3月31日丨潤達醫療(603108.SH)公佈,公司於2020年3月31日接到股東朱文怡通知,獲悉其持有公司的部分股份被質押及解質,其中,質押2342萬股,佔其所持股份比例42.63%;解質1246.3萬股,佔其所持股份比例22.69%。
截至公告日,朱文怡持有公司股份5493.84萬股,佔公司總股本9.48%,累計質押公司股份3944.69萬股,佔其持股總數的71.80%,佔公司總股本的6.81%。朱文怡的一致行動人劉輝持有公司股份4202.88萬股,佔公司總股本7.25%,累計質押公司股份2479.8萬股,佔其持股總數的59.00%,佔公司總股本的4.28%。朱文怡及劉輝合計持有公司股份9696.72萬股,佔公司總股本16.73%,累計質押公司股份合計6424.49萬股,佔其持股總數的66.25%,佔公司總股本的11.09%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.